Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maria L Motti
AurkA Inhibitors Enhance the Effects of B-Raf and MEK Inhibitors in Melanoma Treatment
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
Evaluation of the Immunologic Impact of RAF Inhibitors to Guide Optimal Combination of RAF Inhibitors and Immunotherapy for the Treatment of Advanced Melanoma
HDAC Inhibitors Enhance the Immunotherapy Response of Melanoma Cells
Oncotarget
Oncology
RAF Dimer Inhibition Enhances the Antitumor Activity of MEK Inhibitors in K‐RAS Mutant Tumors
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Comparison of Responses of Human Melanoma Cell Lines to MEK and BRAF Inhibitors
Frontiers in Genetics
Genetics
Molecular Medicine
Inhibitors of Pan-Pi3k Signaling Synergize With BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth
Frontiers in Oncology
Cancer Research
Oncology
Combination Therapy With BRAF and MEK Inhibitors for Melanoma: Latest Evidence and Place in Therapy
Therapeutic Advances in Medical Oncology
Oncology
BET Bromodomain Inhibitors Synergize With ATR Inhibitors in Melanoma in Melanoma
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
B-Raf Inhibitors Induce Epithelial Differentiation in BRAF-Mutant Colorectal Cancer Cells
Cancer Research
Cancer Research
Oncology
Effects of RAF Inhibitors on PI3K/AKT Signalling Depend on Mutational Status of the RAS/RAF Signalling Axis
Oncotarget
Oncology
